Compounds > conivaptan
Page last updated: 2024-09-04

conivaptan and oxytocin

conivaptan has been researched along with oxytocin in 5 studies

Compound Research Comparison

Studies
(conivaptan)		Trials
(conivaptan)		Recent Studies (post-2010)
(conivaptan)		Studies
(oxytocin)		Trials
(oxytocin)		Recent Studies (post-2010) (oxytocin)
188176421,6111,8315,773

Protein Interaction Comparison

ProteinTaxonomyconivaptan (IC50)oxytocin (IC50)
Oxytocin receptorHomo sapiens (human)0.0027

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T2
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Becker, JAJ; Bonnet, D; Durroux, T; Frantz, MC; Gandía, J; Hibert, M; Le Merrer, J; Loison, S; Marsol, C; Mouillac, B; Pellissier, LP; Pflimlin, E; Valencia, C; Villa, P1
Chini, B; Durroux, T; Guillon, G; Manning, M; Mouillac, B; Stoev, S1

Reviews

2 review(s) available for conivaptan and oxytocin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Progress in brain research, 2008, Volume: 170

    Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Lypressin; Oligopeptides; Oxytocin; Peptides; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Structure-Activity Relationship; Terlipressin; Uterus; Vasodilator Agents; Vasopressins

2008

Other Studies

3 other study(ies) available for conivaptan and oxytocin

ArticleYear
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 357, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Binding, Competitive; Calcium; Cloning, Molecular; COS Cells; Cyclic AMP; Dose-Response Relationship, Drug; Hemostatics; Humans; Radioligand Assay; Receptors, Vasopressin; Regression Analysis; Renal Agents; Transfection

1998
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
    British journal of pharmacology, 1998, Volume: 125, Issue:7

    Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium

1998
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
    Journal of medicinal chemistry, 2018, 10-11, Volume: 61, Issue:19

    Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Disease Models, Animal; Female; HEK293 Cells; Humans; Interpersonal Relations; Ligands; Male; Mice; Mice, Knockout; Psychotropic Drugs; Pyrazoles; Pyrrolidines; Receptors, Opioid, mu; Receptors, Oxytocin; Structure-Activity Relationship

2018